SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Current Ratio

14.80×

TTM · Retrieved:

DMRA logo

DMRA Current Ratio

Current (TTM)14.80×
DMRA Current Ratio (7.87× → 14.80×)
High-resolution chart · PNG

What is current ratio?

The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.

Compare current ratio

Values are from the market snapshot of .

DMRA current ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Current Ratio — Annual fiscal periods
Period endingCurrent RatioChange
12.9783×−7.74%
14.0677×+123.02%
6.3077×+9.62%
5.754×−76.25%
24.2302×−20.34%
30.4159×+329.93%
7.0746×−10.07%
7.8668×—

Frequently asked questions: DMRA current ratio

What is Damora Therapeutics, Inc. (DMRA)'s current current ratio?

Damora Therapeutics, Inc. (DMRA)'s latest reported current ratio (TTM) is 14.80× as of Nov 21, 2026. The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.

How much historical current ratio data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s current ratio, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's current ratio to peers or set an alert?

You can compare DMRA's current ratio directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.